Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-13-000820
Filing Date
2013-07-16
Accepted
2013-07-16 20:26:31
Documents
1
Period of Report
2013-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8529
  Complete submission text file 0000904454-13-000820.txt   10112
Mailing Address 5880 PACIFIC CENTER BLVD SAN DIEGO CA 92121-4204
Business Address
BLAIR JAMES C (Reporting) CIK: 0001024000 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 13971364
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

EIN.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations